F Graeme-Cook
Overview
Explore the profile of F Graeme-Cook including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
516
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farrell J, Graeme-Cook F, Kelsey P
Endoscopy
. 2003 Oct;
35(10):823-9.
PMID: 14551859
Background And Study Aims: Angiographic and surgical therapy are standards of care for persistent diverticular bleeding. Colonoscopic intervention using epinephrine injection, multipolar electrocautery, and placement of an Endoclip has not...
2.
Sandborn W, Sands B, Wolf D, Valentine J, Safdi M, Katz S, et al.
Aliment Pharmacol Ther
. 2003 Jun;
17(11):1355-64.
PMID: 12786629
Background: Repifermin (keratinocyte growth factor-2) has been shown to reduce inflammation in animal models of colitis. Aim: To evaluate repifermin for the treatment of active ulcerative colitis. Methods: Eighty-eight patients...
3.
Balcom 4th J, Keck T, Warshaw A, Antoniu B, Graeme-Cook F, Fernandez-Del Castillo C
Ann Surg
. 2001 Aug;
234(3):344-50; discussion 350-1.
PMID: 11524587
Objective: To determine the presence of telomerase activity in a variety of periampullary malignancies and pancreatic diseases and quantify its activity to establish any association with the stage or aggressiveness...
4.
Zgraggen K, Warshaw A, Werner J, Graeme-Cook F, Jimenez R, Fernandez-Del Castillo C
Ann Surg
. 2001 Apr;
233(5):688-95.
PMID: 11323507
Objective: To investigate whether a high-fat/high-protein diet (HFPD) acts as a promoter of the natural course of cancer growth in the 7,12-dimethylbenzanthracene (DMBA)-induced ductal pancreatic cancer model in rats. Summary...
5.
Chung D, Brown S, Graeme-Cook F, Seto M, Warshaw A, Jensen R, et al.
J Clin Endocrinol Metab
. 2000 Nov;
85(11):4373-8.
PMID: 11095482
The molecular pathogenesis of human pancreatic endocrine tumors (PETs) is poorly understood. Three independent animal models have pointed to the pivotal role of the G1/S cell cycle transition in pancreatic...
6.
Morgan J, Yin Y, Borowsky A, Kuo F, Nourmand N, Koontz J, et al.
Cancer Res
. 2000 Jan;
59(24):6205-13.
PMID: 10626814
Lymphomas arising in mucosa-associated lymphoid tissue (MALT) are indolent B-cell tumors that have a predilection for epithelial sites and often develop in a setting of chronic inflammation or autoimmunity. As...
7.
Sohn K, Puchyr M, Salomon R, Graeme-Cook F, Fung L, Choi S, et al.
Carcinogenesis
. 1999 Dec;
20(12):2345-50.
PMID: 10590231
Dietary inadequacy of folate enhances and folate supplementation suppresses colorectal carcinogenesis in the dimethylhydrazine rat model. Folate is an essential factor for DNA methylation and the de novo biosynthesis of...
8.
Jimenez R, Zgraggen K, Hartwig W, Graeme-Cook F, Warshaw A, Fernandez-Del Castillo C
Am J Pathol
. 1999 May;
154(4):1223-9.
PMID: 10233860
Dimethylbenzanthracene (DMBA) induces pancreatic adenocarcinomas in rats 9 months after carcinogen exposure, with precursor lesions (tubular complexes) developing 1 month after initiation of treatment. Because previous studies have suggested an...
9.
Fung C, Grossbard M, Linggood R, Younger J, Flieder A, Harris N, et al.
Cancer
. 1999 Jan;
85(1):9-17.
PMID: 9921968
Background: Although antibiotic therapy is emerging as effective initial treatment for patients with gastric lymphoma of mucosa-associated lymphoid tissue (MALT), there is a subset of patients for whom antibiotics are...
10.
Toth C, Pascual M, Chung R, Graeme-Cook F, Dienstag J, Bhan A, et al.
Transplantation
. 1998 Nov;
66(9):1254-8.
PMID: 9825826
Fibrosing cholestatic hepatitis (FCH) has recently been described after solid organ transplantation in patients with hepatitis C virus (HCV) infection. Typically, FCH is characterized by an ominous clinical course leading...